A detailed history of First Financial Bankshares Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, First Financial Bankshares Inc holds 17,734 shares of NBIX stock, worth $2.42 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
17,734
Previous 16,676 6.34%
Holding current value
$2.42 Million
Previous $2.3 Billion 11.0%
% of portfolio
0.04%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$114.58 - $153.15 $121,225 - $162,032
1,058 Added 6.34%
17,734 $2.04 Billion
Q2 2024

Aug 13, 2024

BUY
$130.86 - $143.19 $63,205 - $69,160
483 Added 2.98%
16,676 $2.3 Billion
Q1 2024

May 14, 2024

BUY
$130.4 - $143.74 $50,986 - $56,202
391 Added 2.47%
16,193 $2.23 Billion
Q4 2023

Feb 14, 2024

BUY
$106.07 - $132.76 $1.68 Million - $2.1 Million
15,802 New
15,802 $2.08 Billion

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track First Financial Bankshares Inc Portfolio

Follow First Financial Bankshares Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Financial Bankshares Inc, based on Form 13F filings with the SEC.

News

Stay updated on First Financial Bankshares Inc with notifications on news.